Temporal correlation between transcriptional changes and increased synthesis of hyaluronan in experimental cardiac hypertrophy

Genomics

Volumn 96, Issue 2, 2010, Pages 73-81

  Hellman, Urban ^a   Mörner, Stellan ^a   Engström Laurent, Anna ^a   Samuel, Jane Lise ^b,c   Waldenström, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b APHP   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cardiac hypertrophy; Extracellular matrix; Gene expression; Hyaluronan; Remodeling

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; EARLY GROWTH RESPONSE FACTOR 1; HYALURONIC ACID; MYC PROTEIN; PROTEIN FOS; TRANSCRIPTION FACTOR JUNB; ANGIOTENSIN CONVERTING ENZYME 2; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CARDIOMEGALY; DNA MICROARRAY; FACTORIAL ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; IMMEDIATE EARLY GENE; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; SPECTROPHOTOMETRY; TIME; WISTAR RAT;

ANIMALS; CARDIOMEGALY; FACTOR ANALYSIS, STATISTICAL; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; HYALURONIC ACID; MALE; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRANSCRIPTION FACTORS;

RATTUS;

EID: 77955327301     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.04.003     Document Type: Article

References (55)

1. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., Colucci W.S., Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 2005, 115:2108-2118.
2. Corda S., Samuel J.L., Rappaport L. Extracellular matrix and growth factors during heart growth. Heart Fail. Rev. 2000, 5:119-130.
3. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., Taylor D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008, 14:213-221.
4. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
5. Klein E.A., Yin L., Kothapalli D., Castagnino P., Byfield F.J., Xu T., Levental I., Hawthorne E., Janmey P.A., Assoian R.K. Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening. Curr. Biol. 2009.
6. Weinberg E.O., Mirotsou M., Gannon J., Dzau V.J., Lee R.T., Pratt R.E. Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. Physiol. Genomics 2003, 12:113-127.
7. Mirotsou M., Watanabe C.M., Schultz P.G., Pratt R.E., Dzau V.J. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol. Genomics 2003, 15:115-126.
8. Zhao M., Chow A., Powers J., Fajardo G., Bernstein D. Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol. Genomics 2004, 19:93-105.
9. Strom C.C., Kruhoffer M., Knudsen S., Stensgaard-Hansen F., Jonassen T.E., Orntoft T.F., Haunso S., Sheikh S.P. Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy. Comp. Funct. Genomics 2004, 5:459-470.
10. Wagner R.A., Tabibiazar R., Powers J., Bernstein D., Quertermous T. Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses. J. Mol. Cell. Cardiol. 2004, 37:1159-1170.
11. van den Bosch B.J., Lindsey P.J., van den Burg C.M., van der Vlies S.A., Lips D.J., van der Vusse G.J., Ayoubi T.A., Doevendans P.A., Smeets H.J. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics 2006, 88:480-488.
12. Cerutti C., Kurdi M., Bricca G., Hodroj W., Paultre C., Randon J., Gustin M.P. Transcriptional alterations in the left ventricle of three hypertensive rat models. Physiol. Genomics 2006, 27:295-308.
13. Rajan S., Williams S.S., Jagatheesan G., Ahmed R.P., Fuller-Bicer G., Schwartz A., Aronow B.J., Wieczorek D.F. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy. Physiol. Genomics 2006, 27:309-317.
14. Rysa J., Leskinen H., Ilves M., Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 2005, 45:927-933.
15. Frank D., Kuhn C., Brors B., Hanselmann C., Ludde M., Katus H.A., Frey N. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 2008, 51:309-318.
16. Mirotsou M., Dzau V.J., Pratt R.E., Weinberg E.O. Physiological genomics of cardiac disease: quantitative relationships between gene expression and left ventricular hypertrophy. Physiol. Genomics 2006, 27:86-94.
17. Sheehy S.P., Huang S., Parker K.K. Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy. Circ. Cardiovasc. Genet. 2009, 116-124.
18. Comper W.D., Laurent T.C. Physiological function of connective tissue polysaccharides. Physiol. Rev. 1978, 58:255-315.
19. Adamia S., Maxwell C.A., Pilarski L.M. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5:3-14.
20. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002, 21:25-29.
21. Itano N., Zhuo L., Kimata K. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci. 2008, 99:1720-1725.
22. Toole B.P., Slomiany M.G. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells. Semin. Cancer Biol. 2008, 18:244-250.
23. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A., Kubalak S., Klewer S.E., McDonald J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 2000, 106:349-360.
24. Hellman U., Hellstrom M., Morner S., Engstrom-Laurent A., Aberg A.M., Oliviero P., Samuel J.L., Waldenstrom A. Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat. Cell Tissue Res. 2008, 332:49-56.
25. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 1995, 57:289-300.
26. Reiner A., Yekutieli D., Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375.
27. Barry S.P., Davidson S.M., Townsend P.A. Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell Biol. 2008, 40:2023-2039.
28. A. Biosystems, ABI PRISM 7700 Sequence Detection System User Bulletin #2: Relative Quantification of Gene Expression, P/N 4303859B, 1997.
29. Waldenstrom A., Martinussen H.J., Gerdin B., Hallgren R. Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J. Clin. Invest. 1991, 88:1622-1628.
30. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996, 93:841-842.
31. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 2007, 292:C82-C97.
32. Mercure C., Yogi A., Callera G.E., Aranha A.B., Bader M., Ferreira A.J., Santos R.A., Walther T., Touyz R.M., Reudelhuber T.L. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ. Res 2008, 103:1319-1326.
33. Vesely P.W., Staber P.B., Hoefler G., Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat. Res. 2009, 682:7-12.
34. Zhong W., Mao S., Tobis S., Angelis E., Jordan M.C., Roos K.P., Fishbein M.C., de Alboran I.M., MacLellan W.R. Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J. 2006, 25:3869-3879.
35. Tan N.Y., Khachigian L.M. Sp1 phosphorylation and its regulation of gene transcription. Mol. Cell Biol. 2009, 29:2483-2488.
36. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
37. Lijnen P., Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J. Mol. Cell. Cardiol. 1999, 31:949-970.
38. Yamazaki T., Komuro I., Yazaki Y. Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J. Mol. Cell Cardiol. 1995, 27:133-140.
39. Yamazaki T., Komuro I., Kudoh S., Zou Y., Shiojima I., Mizuno T., Takano H., Hiroi Y., Ueki K., Tobe K., et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ. Res. 1995, 77:258-265.
40. Khachigian L.M. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 2006, 98:186-191.
41. Specks U., Mayer U., Nischt R., Spissinger T., Mann K., Timpl R., Engel J., Chu M.L. Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J. 1992, 11:4281-4290.
42. Matsumoto K., Shionyu M., Go M., Shimizu K., Shinomura T., Kimata K., Watanabe H. Distinct interaction of versican/PG-M with hyaluronan and link protein. J. Biol. Chem. 2003, 278:41205-41212.
43. Spicer A.P., Joo A., Bowling R.A. A hyaluronan binding link protein gene family whose members are physically linked adjacent to chondroitin sulfate proteoglycan core protein genes: the missing links. J. Biol. Chem. 2003, 278:21083-21091.
44. Ricciardelli C., Mayne K., Sykes P.J., Raymond W.A., McCaul K., Marshall V.R., Horsfall D.J. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin. Cancer Res. 1998, 4:963-971.
45. Touab M., Villena J., Barranco C., Arumi-Uria M., Bassols A. Versican is differentially expressed in human melanoma and may play a role in tumor development. Am. J. Pathol. 2002, 160:549-557.
46. Bereczki E., Gonda S., Csont T., Korpos E., Zvara A., Ferdinandy P., Santha M. Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study. J. Proteome Res. 2007, 6:854-861.
47. Pardo J.V., Siliciano J.D., Craig S.W. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:1008-1012.
48. Ross R.S., Pham C., Shai S.Y., Goldhaber J.I., Fenczik C., Glembotski C.C., Ginsberg M.H., Loftus J.C. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ. Res. 1998, 82:1160-1172.
49. Hayata N., Fujio Y., Yamamoto Y., Iwakura T., Obana M., Takai M., Mohri T., Nonen S., Maeda M., Azuma J. Connective tissue growth factor induces cardiac hypertrophy through Akt signaling. Biochem. Biophys. Res. Commun. 2008, 370:274-278.
50. Gabrielsen A., Lawler P.R., Yongzhong W., Steinbruchel D., Blagoja D., Paulsson-Berne G., Kastrup J., Hansson G.K. Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J. Mol. Cell Cardiol. 2007, 42:870-883.
51. Villarreal F.J., Dillmann W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am. J. Physiol. 1992, 262:H1861-H1866.
52. Lim J.Y., Park S.J., Hwang H.Y., Park E.J., Nam J.H., Kim J., Park S.I. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J. Mol. Cell Cardiol. 2005, 39:627-636.
53. Heldin P., Laurent T.C., Heldin C.H. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem. J. 1989, 258:919-922.
54. Berdiaki A., Zafiropoulos A., Fthenou E., Katonis P., Tsatsakis A., Karamanos N.K., Tzanakakis G.N. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochim. Biophys. Acta 2008, 1780:194-202.
55. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.